GL1X · GenesisL1 explorer

MolNFT v1 · #186246 · protein

Structure of human SHP2 in complex with compound 27

7R7I · Tyrosine-protein phosphatase non-receptor type 11: “Structure of human SHP2 in complex with compound 27”. X-ray diffraction, 1 ligand (3CW), 11 pockets (best druggability 0.78). MolNFT v1 #186246 on GenesisL1: 3D structure, binding…

PDB
7R7I
Type
protein
Length
977 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein phosphatase non-receptor type 11
EC
3.1.3.48
UniProt
Q06124
Ligands
3CW
Pockets
11 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 29% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein48929% helix, 25% strandQ06124
BTyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein48830% helix, 25% strandQ06124

Ligands and binding sites

  • 3CW · [3-(4-amino-4-methylpiperidin-1-yl)-6-(2,3-dichlorophenyl)-5-methylpyrazin-2-yl]methanol · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19830.780.8092empty
24840.680.79583CW
34150.650.79363CW
41710.610.8428empty
51170.500.8031empty

Interfaces

1 interface between chains.

  • A–B · 731 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 7R7I · Structure of human SHP2 in complex with compound 27 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.